Solvay Specialty Polymers





Company Headquarters

4500 McGinnis Ferry Road
Alpharetta, GA 30005
United States

Buyer's Guide

    Related Content

    • Paragon Medical Launches Reusable Intubation Shield For Healthcare Workers

      Paragon Medical Launches Reusable Intubation Shield For Healthcare Workers

      The shield provides a barrier between the healthcare professional and patient during intubation and extubation procedures to reduce exposure.
      PR Newswire 05.06.20

    • Materials
      Material Matters: New Offerings for Orthopedic Technologies

      Material Matters: New Offerings for Orthopedic Technologies

      An examination of the transformation within orthopedic material selection from traditional metals to newer alternatives.
      Mark Crawford, Contributing Writer 11.30.18

    • Instruments | Large Joint
      A Gathering of Industry

      A Gathering of Industry

      ...
      Sean Fenske, Editor-in-Chief 03.21.18


    • Biologics | Large Joint | Trauma/Sports
      Welcoming Party

      Welcoming Party

      ...
      Sean Fenske, Editor 03.23.16

    • Study Compares Carbon Footprint of Single-Use and Reusable Surgical Instruments

      Study Compares Carbon Footprint of Single-Use and Reusable Surgical Instruments

      Analysis shows they share a comparable footprint.
      Solvay Specialty Polymers 03.07.16

    • Materials | Spine/Neurology
      Vertera Spine Gets FDA Clearance for Spine Implant with Unique Porous PEEK

      Vertera Spine Gets FDA Clearance for Spine Implant with Unique Porous PEEK

      Technology is based on Zeniva PEEK resin from Solvay Specialty Polymers.
      Christopher Delporte, Editorial Director 10.21.15


    • Spine/Neurology

      Vertera Spine Earns Clearance for Cervical Interbody Fusion Device

      The device is made entirely from PEEK.
      10.07.15

    • The ‘Factoring’ of Orthopedic Molding

      Molding providers use advanced technologies, materials and methods to meet the complex design and end-use needs of device makers.
      Mark Crawford, Contributing Writer 04.01.15